Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Beckers

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
European Journal of Endocrinology|March 2, 2017
Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly RegistryLuigi Maione, Thierry Brue, Albert Beckers, et al.
Pituitary|November 12, 2025
Loss of heterozygosity and absence of MAX immunostaining in a prolactinoma associated with multiple endocrine neoplasia type 5 (MEN5)Brigitte Delemer, Simona M Florea, Benedicte Decoudier, et al.
Pituitary|December 12, 2022
Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literatureDorothee Cäcilia Spille, Elena Vorona, Michael P Catalino, et al.
Nature Communications|September 22, 2020
GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G<sub>s</sub> and G<sub>q/11</sub>Dayana Abboud, Adrian F Daly, Nadine Dupuis, et al.
Endocrine|October 7, 2016
Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemiaLaurent Vroonen, Patrizio Lancellotti, Monica Tomé Garcia, et al.
International Journal of Cancer|May 22, 2007
Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: association with tumor size and response to pharmacologic treatmentChristophe Picard, Monique Silvy, Corinne Gerard, et al.
Endocrine|November 18, 2016
Erratum to: Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemiaLaurent Vroonen, Patrizio Lancellotti, Monica Tomé Garcia, et al.
Endocrine Connections|March 2, 2019
AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral centerAdrian F Daly, David A Cano, Eva Venegas-Moreno, et al.
Endocrine Connections|December 23, 2021
Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South AfricaDebra M Gordon, Pablo Beckers, Emilie Castermans, et al.
Endocrine|November 30, 2019
Long-term remission of disseminated parathyroid cancer following immunotherapyMarta Sarquis, Stephen J Marx, Albert Beckers, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
European Journal of Endocrinology|March 2, 2017
Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly RegistryLuigi Maione, Thierry Brue, Albert Beckers, et al.
Pituitary|November 12, 2025
Loss of heterozygosity and absence of MAX immunostaining in a prolactinoma associated with multiple endocrine neoplasia type 5 (MEN5)Brigitte Delemer, Simona M Florea, Benedicte Decoudier, et al.
Pituitary|December 12, 2022
Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literatureDorothee Cäcilia Spille, Elena Vorona, Michael P Catalino, et al.
Nature Communications|September 22, 2020
GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G<sub>s</sub> and G<sub>q/11</sub>Dayana Abboud, Adrian F Daly, Nadine Dupuis, et al.
Endocrine|October 7, 2016
Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemiaLaurent Vroonen, Patrizio Lancellotti, Monica Tomé Garcia, et al.
International Journal of Cancer|May 22, 2007
Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: association with tumor size and response to pharmacologic treatmentChristophe Picard, Monique Silvy, Corinne Gerard, et al.
Endocrine|November 18, 2016
Erratum to: Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemiaLaurent Vroonen, Patrizio Lancellotti, Monica Tomé Garcia, et al.
Endocrine Connections|March 2, 2019
AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral centerAdrian F Daly, David A Cano, Eva Venegas-Moreno, et al.
Endocrine Connections|December 23, 2021
Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South AfricaDebra M Gordon, Pablo Beckers, Emilie Castermans, et al.
Endocrine|November 30, 2019
Long-term remission of disseminated parathyroid cancer following immunotherapyMarta Sarquis, Stephen J Marx, Albert Beckers, et al.
Pageof 18